Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway

References

• Rawshani A, Rawshani A, Franzen S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633–644. doi:10.1056/NEJMoa180025630110583
   PubMed Web of Science ®Google Scholar
• Gilbert RE. Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implications. Circ J. 2013;77(4):849–856.23503045
   PubMed Web of Science ®Google Scholar
• Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017;9(5):434–449. doi:10.1111/1753-0407.1252128044409
   PubMed Web of Science ®Google Scholar
• Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888–1904. doi:10.1161/CIRCULATIONAHA.105.56321316618833
   PubMed Web of Science ®Google Scholar
• van Sloten TT, Henry RM, Dekker JM, et al. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension. 2014;64(6):1299–1305. doi:10.1161/HYPERTENSIONAHA.114.0422125225211
   PubMed Web of Science ®Google Scholar
• Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascul Pharmacol. 2016;84(1–7):1–7. doi:10.1016/j.vph.2016.05.01327256928
   PubMed Web of Science ®Google Scholar
• Ma FX, Zhou B, Chen Z, et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res. 2006;47(6):1227–1237. doi:10.1194/jlr.M500507-JLR20016522925
   PubMed Web of Science ®Google Scholar
• Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol. 2004;31(7):407–413. doi:10.1111/j.1440-1681.2004.04022.x15236625
   PubMed Web of Science ®Google Scholar
• Cheng J, Cui R, Chen CH, et al. Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic Bax leading to apoptosis of differentiated endothelial progenitor cells. Endocrinology. 2007;148(5):2085–2094. doi:10.1210/en.2006-170917289842
   PubMed Web of Science ®Google Scholar
• Chen X, Lin J, Hu T, et al. Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin beta1-RhoA-JNK signaling activation. J Cell Physiol. 2018;234(7):10990–11000. doi:10.1002/jcp.27910.
   Web of Science ®Google Scholar
• Yang M, Tian M, Zhang X, et al. Role of the JAK2/STAT3 signaling pathway in the pathogenesis of type 2 diabetes mellitus with macrovascular complications. Oncotarget. 2017;8(57):96958–96969. doi:10.18632/oncotarget.1855529228585
   PubMedGoogle Scholar
• Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB. Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol. 2018;9(114). doi:10.3389/fphys.2018.00114
   Web of Science ®Google Scholar
• Jiang Y, Wang M, Huang K, et al. Oxidized low-density lipoprotein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. Biochem Biophys Res Commun. 2012;425(2):121–126. doi:10.1016/j.bbrc.2012.07.01122796220
   PubMed Web of Science ®Google Scholar
• Li L, Hou X, Xu R, Liu C, Tu M. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31(1):17–36. doi:10.1111/fcp.1223227567103
   PubMed Web of Science ®Google Scholar
• Song G, Han P, Sun H, et al. Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice. J Int Med Res. 2018;46(7):2883–2897. doi:10.1177/030006051877871129896981
   PubMed Web of Science ®Google Scholar
• Ding Y, Yuan S, Liu X, et al. Protective effects of astragaloside IV on db/db mice with diabetic retinopathy. PLoS One. 2014;9(11):e112207. doi:10.1371/journal.pone.011220725411784
   PubMed Web of Science ®Google Scholar
• Leng B, Tang F, Lu M, et al. Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-kappaB signaling pathway. Life Sci. 2018;209:111–121. doi:10.1016/j.lfs.2018.07.05330081006
   PubMed Web of Science ®Google Scholar
• Zhu J, Cheng X, Wang Q, Zhou Y, Wang F, Zou L. Transplantation of endothelial progenitor cells for improving placental perfusion in preeclamptic rats. Arch Gynecol Obstet. 2015;291(5):1113–1119. doi:10.1007/s00404-014-3522-z25367599
   PubMed Web of Science ®Google Scholar
• Li X, Lin Y, Zhou H, et al. Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension. Clin Exp Hypertens. 2017;39(1):58–64. doi:10.1080/10641963.2016.120060328060542
   PubMed Web of Science ®Google Scholar
• Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol. 2000;20(4):1116–1122.10764682
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Edwards N, Langford-Smith AWW, Wilkinson FL, et al. Endothelial progenitor cells: new targets for therapeutics for inflammatory conditions with high cardiovascular risk. Front Med (Lausanne). 2018;(5):200. doi:10.3389/fmed.2018.00200
   PubMed Web of Science ®Google Scholar
• Medina RJ, Barber CL, Sabatier F, et al. Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Transl Med. 2017;6(5):1316–1320. doi:10.1002/sctm.16-036028296182
   PubMed Web of Science ®Google Scholar
• Hamed S, Brenner B, Abassi Z, et al. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res. 2010;126(3):166–174. doi:10.1016/j.thromres.2010.03.00220347119
   PubMed Web of Science ®Google Scholar
• Lin FY, Tsao NW, Shih CM, et al. The biphasic effects of oxidized-low density lipoprotein on the vasculogenic function of endothelial progenitor cells. PLoS One. 2015;10(5):e0123971. doi:10.1371/journal.pone.012397126017136
   PubMed Web of Science ®Google Scholar
• Pysna A, Bem R, Nemcova A, et al. Endothelial progenitor cells biology in diabetes mellitus and peripheral arterial disease and their therapeutic potential. Stem Cell Rev. 2018;15(2):157–165. doi:10.1007/s12015-018-9863-4.
   Web of Science ®Google Scholar
• Zhao QT, Li BF, Kong H. Roles of Chinese medicine bioactive ingredients in the regulation of cellular function of endothelial progenitor cells. Chin J Nat Med. 2014;12(7):481–487. doi:10.1016/S1875-5364(14)60075-325053545
   PubMed Web of Science ®Google Scholar
• Yang JX, Pan YY, Ge JH, et al. Tanshinone II A attenuates TNF-alpha-induced expression of VCAM-1 and ICAM-1 in endothelial progenitor cells by blocking activation of NF-kappaB. Cell Physiol Biochem. 2016;40(1–2):195–206. doi:10.1159/00045253727855363
   PubMedGoogle Scholar
• Tang Y, Vater C, Jacobi A, Liebers C, Zou X, Stiehler M. Salidroside exerts angiogenic and cytoprotective effects on human bone marrow-derived endothelial progenitor cells via Akt/mTOR/p70S6K and MAPK signalling pathways. Br J Pharmacol. 2014;171(9):2440–2456. doi:10.1111/bph.1261124471788
   PubMed Web of Science ®Google Scholar
• Tang Y, Jacobi A, Vater C, Zou L, Zou X, Stiehler M. Icariin promotes angiogenic differentiation and prevents oxidative stress-induced autophagy in endothelial progenitor cells. Stem Cells. 2015;33(6):1863–1877. doi:10.1002/stem.200525787271
   PubMed Web of Science ®Google Scholar
• Qian W, Cai X, Qian Q, Zhang W, Wang D. Astragaloside IV modulates TGF-beta1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. J Cell Mol Med. 2018;22:4354–4365. doi:10.1111/jcmm.2018.22.issue-929971947
   PubMed Web of Science ®Google Scholar
• Lin XP, Cui HJ, Yang AL, Luo J-K, Tang T. Astragaloside IV improves vasodilatation function by regulating the PI3K/Akt/eNOS signaling pathway in rat aorta endothelial cells. J Vasc Res. 2018;55(3):169–176. doi:10.1159/00048995829972829
   PubMed Web of Science ®Google Scholar
• Hofmann A, Brunssen C, Morawietz H. Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases. Vascul Pharmacol. 2017;107–11. doi:10.1016/j.vph.2017.10.002.
   PubMed Web of Science ®Google Scholar
• Xu X, Gao X, Potter BJ, Cao J-M, Zhang C. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol. 2007;27(4):871–877. doi:10.1161/01.ATV.0000259358.31234.3717272755
   PubMed Web of Science ®Google Scholar
• Mehta JL, Sanada N, Hu CP, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res. 2007;100(11):1634–1642. doi:10.1161/CIRCRESAHA.107.14972417478727
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Q, Xiang M, et al. Astragaloside alleviates hepatic fibrosis function via PAR2 signaling pathway in diabetic rats. Cell Physiol Biochem. 2017;41(3):1156–1166. doi:10.1159/00046412228245465
   PubMedGoogle Scholar
• Chen Q, Su Y, Ju Y, et al. Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis. Biomed Pharmacother. 2018;108(679–686). doi:10.1016/j.biopha.2018.09.049
   Web of Science ®Google Scholar
• Wu M, Han W, Song S, et al. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Mol Cell Endocrinol. 2018;478:115–125. doi:10.1016/j.mce.2018.08.00230098377
   PubMed Web of Science ®Google Scholar
• Ding Z, Liu S, Wang X, et al. LOX-1 - dependent mitochondrial DNA damage and NLRP3 activation during systemic inflammation in mice. Biochem Biophys Res Commun. 2014;451(4):637–643. doi:10.1016/j.bbrc.2014.08.03425130466
   PubMed Web of Science ®Google Scholar
• Wang S, Xie X, Lei T, et al. Statins attenuate activation of the NLRP3 inflammasome by oxidized LDL or TNFalpha in vascular endothelial cells through a PXR-dependent mechanism. Mol Pharmacol. 2017;92(3):256–264. doi:10.1124/mol.116.10810028546421
   PubMed Web of Science ®Google Scholar
• Dai Y, Cao Y, Zhang Z, Vallurupalli S, Mehta JL. Xanthine oxidase induces foam cell formation through LOX-1 and NLRP3 activation. Cardiovasc Drugs Ther. 2017;31(1):19–27. doi:10.1007/s10557-016-6706-x28084571
   PubMed Web of Science ®Google Scholar
• Yang TC, Chang PY, Lu SC. L5-LDL from ST-elevation myocardial infarction patients induces IL-1beta production via LOX-1 and NLRP3 inflammasome activation in macrophages. Am J Physiol Heart Circ Physiol. 2017;312(2):H265–H274. doi:10.1152/ajpheart.00509.201627864235
   PubMed Web of Science ®Google Scholar